LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma

Immunotherapy with immune checkpoint molecule-specific monoclonal antibody have obtained encouraging results from preclinical studies and clinical trials, which promoted us to explore whether this kind of immunotherapy could be applicable to head and neck squamous cell carcinoma (HNSCC). Lymphocyte...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Deng, Wei-Wei, Mao, Liang, Yu, Guang-Tao, Bu, Lin-Lin, Ma, Si-Rui, Liu, Bing, Gutkind, J. Silvio, Kulkarni, Ashok B., Zhang, Wen-Feng, Sun, Zhi-Jun
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139652/
https://ncbi.nlm.nih.gov/pubmed/27999760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1239005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados